vs

Side-by-side financial comparison of FLUSHING FINANCIAL CORP (FFIC) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $58.8M, roughly 1.3× FLUSHING FINANCIAL CORP). On growth, FLUSHING FINANCIAL CORP posted the faster year-over-year revenue change (2597.7% vs 27.7%). FLUSHING FINANCIAL CORP produced more free cash flow last quarter ($55.8M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 13.7%).

Flagstar Bank, N.A. (FLG), is an American regional financial services holding company headquartered in Hicksville, New York. In 2023, the bank operated 395 branches However, they rebranded all of these under the Flagstar name on February 21, 2024.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

FFIC vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.3× larger
PBYI
$75.5M
$58.8M
FFIC
Growing faster (revenue YoY)
FFIC
FFIC
+2569.9% gap
FFIC
2597.7%
27.7%
PBYI
More free cash flow
FFIC
FFIC
$41.4M more FCF
FFIC
$55.8M
$14.4M
PBYI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
13.7%
FFIC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FFIC
FFIC
PBYI
PBYI
Revenue
$58.8M
$75.5M
Net Profit
$4.0M
Gross Margin
69.3%
Operating Margin
13.3%
22.7%
Net Margin
6.8%
Revenue YoY
2597.7%
27.7%
Net Profit YoY
108.2%
EPS (diluted)
$0.12
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FFIC
FFIC
PBYI
PBYI
Q4 25
$58.8M
$75.5M
Q3 25
$58.6M
$54.5M
Q2 25
$63.5M
$52.4M
Q1 25
$58.1M
$46.0M
Q4 24
$2.2M
$59.1M
Q3 24
$51.9M
$80.5M
Q2 24
$47.0M
$47.1M
Q1 24
$45.5M
$43.8M
Net Profit
FFIC
FFIC
PBYI
PBYI
Q4 25
$4.0M
Q3 25
$10.4M
$8.8M
Q2 25
$14.2M
$5.9M
Q1 25
$-9.8M
$3.0M
Q4 24
$-49.2M
Q3 24
$8.9M
$20.3M
Q2 24
$5.3M
$-4.5M
Q1 24
$3.7M
$-4.8M
Gross Margin
FFIC
FFIC
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
FFIC
FFIC
PBYI
PBYI
Q4 25
13.3%
22.7%
Q3 25
23.4%
17.6%
Q2 25
29.8%
12.7%
Q1 25
-10.2%
8.7%
Q4 24
-3296.2%
22.6%
Q3 24
22.1%
27.4%
Q2 24
15.2%
-4.6%
Q1 24
11.0%
-5.3%
Net Margin
FFIC
FFIC
PBYI
PBYI
Q4 25
6.8%
Q3 25
17.8%
16.2%
Q2 25
22.4%
11.2%
Q1 25
-16.9%
6.5%
Q4 24
-2258.9%
Q3 24
17.2%
25.2%
Q2 24
11.3%
-9.6%
Q1 24
8.1%
-11.0%
EPS (diluted)
FFIC
FFIC
PBYI
PBYI
Q4 25
$0.12
$0.26
Q3 25
$0.30
$0.17
Q2 25
$0.41
$0.12
Q1 25
$-0.29
$0.06
Q4 24
$-1.67
$0.40
Q3 24
$0.30
$0.41
Q2 24
$0.18
$-0.09
Q1 24
$0.12
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FFIC
FFIC
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$708.0M
$130.3M
Total Assets
$8.7B
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FFIC
FFIC
PBYI
PBYI
Q4 25
$97.5M
Q3 25
$94.4M
Q2 25
$96.0M
Q1 25
$93.2M
Q4 24
$101.0M
Q3 24
$96.7M
Q2 24
$96.8M
Q1 24
$107.2M
Total Debt
FFIC
FFIC
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
FFIC
FFIC
PBYI
PBYI
Q4 25
$708.0M
$130.3M
Q3 25
$711.2M
$115.3M
Q2 25
$706.4M
$104.7M
Q1 25
$702.9M
$97.1M
Q4 24
$724.5M
$92.1M
Q3 24
$666.9M
$71.1M
Q2 24
$665.3M
$48.5M
Q1 24
$669.8M
$51.0M
Total Assets
FFIC
FFIC
PBYI
PBYI
Q4 25
$8.7B
$216.3M
Q3 25
$8.9B
$202.9M
Q2 25
$8.8B
$194.9M
Q1 25
$9.0B
$196.2M
Q4 24
$9.0B
$213.3M
Q3 24
$9.3B
$220.7M
Q2 24
$9.1B
$205.0M
Q1 24
$8.8B
$214.1M
Debt / Equity
FFIC
FFIC
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FFIC
FFIC
PBYI
PBYI
Operating Cash FlowLast quarter
$61.0M
$14.4M
Free Cash FlowOCF − Capex
$55.8M
$14.4M
FCF MarginFCF / Revenue
94.9%
19.1%
Capex IntensityCapex / Revenue
8.9%
0.0%
Cash ConversionOCF / Net Profit
15.16×
TTM Free Cash FlowTrailing 4 quarters
$104.7M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FFIC
FFIC
PBYI
PBYI
Q4 25
$61.0M
$14.4M
Q3 25
$19.6M
$9.7M
Q2 25
$25.8M
$14.1M
Q1 25
$6.9M
$3.6M
Q4 24
$12.4M
$15.6M
Q3 24
$5.4M
$11.0M
Q2 24
$9.6M
$1.0M
Q1 24
$-6.2M
$11.2M
Free Cash Flow
FFIC
FFIC
PBYI
PBYI
Q4 25
$55.8M
$14.4M
Q3 25
$19.3M
$9.7M
Q2 25
$24.4M
$14.1M
Q1 25
$5.2M
$3.6M
Q4 24
$10.1M
$15.6M
Q3 24
$4.8M
$11.0M
Q2 24
$8.8M
$1.0M
Q1 24
$-6.5M
FCF Margin
FFIC
FFIC
PBYI
PBYI
Q4 25
94.9%
19.1%
Q3 25
33.0%
17.7%
Q2 25
38.5%
26.8%
Q1 25
8.9%
7.7%
Q4 24
463.4%
26.4%
Q3 24
9.3%
13.7%
Q2 24
18.7%
2.1%
Q1 24
-14.3%
Capex Intensity
FFIC
FFIC
PBYI
PBYI
Q4 25
8.9%
0.0%
Q3 25
0.4%
0.0%
Q2 25
2.1%
0.0%
Q1 25
2.9%
0.1%
Q4 24
106.0%
0.0%
Q3 24
1.1%
0.0%
Q2 24
1.7%
0.0%
Q1 24
0.6%
0.0%
Cash Conversion
FFIC
FFIC
PBYI
PBYI
Q4 25
15.16×
Q3 25
1.87×
1.10×
Q2 25
1.81×
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.61×
0.54×
Q2 24
1.80×
Q1 24
-1.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons